Daniel P. Cahill, M.D.,Ph.D.
Co-Author
This page shows the publications co-authored by Daniel Cahill and Isabel Arrillaga-Romany.
Connection Strength
0.872
-
Enhancing demethylation-induced differentiation in IDH-mutant glioma. Neuro Oncol. 2022 Mar 03.
Score: 0.247
-
Accelerated progression of IDH mutant glioma after first recurrence. Neuro Oncol. 2019 05 06; 21(5):669-677.
Score: 0.203
-
Performance of a Hospital Pathway for Patients With a New Single Brain Mass. J Oncol Pract. 2019 Mar; 15(3):e211-e218.
Score: 0.200
-
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas. Nat Commun. 2022 Mar 14; 13(1):1325.
Score: 0.062
-
TERT and DNMT1 expression predict sensitivity to decitabine in gliomas. Neuro Oncol. 2021 01 30; 23(1):76-87.
Score: 0.057
-
Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma. JCO Precis Oncol. 2020; 4.
Score: 0.055
-
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate. Nat Commun. 2018 04 16; 9(1):1474.
Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.